Category B2. Studies in animals are inadequate or may be lacking but available data show no evidence of an increased occurrence of foetal damage. The safety of benzydamine hydrochloride has not been established in pregnant patients. Risk to benefit ratio should be established if benzydamine hydrochloride anti-inflammatory lozenge are to be used in this patients.
Sign Out
